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Chromium(VI)-induced damage to the cytoskeleton and cell death in isolated
hepatocytes
M. Gunaratnam and M. H. Grant1
Bioengineering Unit, Strathclyde University, Wolfson Centre, Glasgow G4 0NW, U.K.
Abstract
Cr(VI) is a known human carcinogen. Although it
has been investigated widely, the mechanism(s)
of its action is}are not fully understood.The aim of
this study was to evaluate Cr(VI)-induced damage
to the cell cytoskeleton and the mode of cell death
in primary cultures of hepatocytes. Exposure of
the cultured cells (10&}cm#) to 1 and 5 lM Cr(VI)
for 24 h resulted in loss of the cell cytoskeleton,
and this was accompanied by membrane bleb-
bing and shrinking of the cell. Staining of the cells
with annexin V and propidium iodide showed that
Cr(VI) induces apoptosis at low concentrations
(5 lM), whereas at higher concentrations (25 lM)
it induces necrosis. This study shows that Cr(VI)
causes damage to the cell cytoskeleton, and induces
apoptosis at low concentrations. However, the
importance of necrosis and apoptosis in vivo, and
the effects of longer exposure times, which simu-
late environmental and occupational exposure to
Cr(VI), remain to be investigated.
Introduction
Chromium exists in the environment pre-
dominantly as two valence states, Cr(III) and
Cr(VI). It has a wide range of applications in the
chemical industry, for example in production of
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anti-corrosion paints and in stainless steel welding
[1]. Another major use of chromium is in the alloys
used in orthopaedic implants. The in vivo degra-
dation of implants leads to high levels of metal ions
in plasma and tissue [14], which may cause a wide
range of adverse biological effects in the patient.
Hexavalent chromium [Cr(VI)] is thought to be
the most toxic of the released metal ions [2,3],
and it has been classified as an environmental and
occupational human carcinogen by the Inter-
national Agency for Research on Cancer (IARC).
The carcinogenic effects of Cr(VI) have been
proven in various cell and animal models, although
the precise mechanisms are not yet fully under-
stood. Once Cr(VI) enters cells, it is reduced to
reactive intermediates such as Cr(V), Cr(IV) and
Cr(III) by both enzymic and non-enzymic reduc-
tants [4]. During this reduction, it produces
reactive oxygen species. These reactive Cr inter-
mediates and reactive oxygen species react with
cellular components such as DNA, RNA, protein
and organelles, and eventually lead to toxicity. If
the cell is damaged by exogenous compounds,
such as Cr(VI), the cell cycle will be delayed to
allow for repair of the macromolecules to take
place. However, if the damage is beyond repair,
the cell will undergo apoptosis [5]. It has been
proposed that Cr(VI) cytotoxicity may lead to cell-
cycle arrest, apoptosis and}or neoplastic trans-
formation [6]. In this study we have investigated
Cr(VI)-induced morphological changes using cul-
tured hepatocytes as an in vitro model. We have
observed the effect of Cr(VI) on the cell cyto-
skeleton, and on the mode of cell death induced by
the metal.
Materials and methods
Preparation of rat hepatocytes
Hepatocytes were isolated from male Sprague–
Dawley rats (180–220 g) by perfusion of the liver
with collagenase [7]. The viability of the cell
suspension was determined by Trypan Blue ex-
clusion (typically above 80%). Cells were cul-
tured (5‹10& cells}chamber) on collagen-coated
(collagen type I at 0.03 mg}cm#) sterile chamber
slides (4.2 cm#). Cells were incubated in Chee’s
medium supplemented with 5% fetal calf serum
for 4 h in 5% CO
#
}air before exposure to Cr(VI).
Cr(VI) exposure and detection of cytoskeletal
damage
For the detection of cytoskeletal damage, FITC-
labelled phalloidin (Sigma) was used to stain the
F-actin [8]. After 4 h in primary culture, the cells
were exposed to 0, 1 and 5 lM Cr(VI) for 24 h.
Cells were then washed twice with PBS, pH 7.4,
and fixed with 1 ml of 4% formaldehyde in PBS
for 20 min. Following fixation, cells were washed
in PBS and incubated with 100 ll of FITC-
phalloidin (diluted 1:500 in PBS) for 1 h in the
dark at room temperature in a humid atmosphere.
Cells were washed as described before, and ex-
amined under confocal laser scanning microscope
at 488 nm, excitation wavelength using a ‹40 oil
immersion lens (numerical aperturefl1.3).
Cr(VI) exposure and mode of cell death
Detection of the mode of cell death was investi-
gated using the FITC-Annexin V Apoptosis Kit
(Sigma). Cells were set up as before in chamber
slides, and after 4 h in primary culture they were
exposed to 0, 5 and 25 lM Cr(VI) for 24 h.
Samples were washed as before. To each chamber
1 ml of binding buffer was added, followed by 5 ll
of annexin V-FITC conjugate and samples incu-
bated for 9 min at room temperature in the
dark. After this time 10 ll of propidium iodide
(0.8 lg}ml) was added and samples incubated for
a further minute. Cells were washed twice with
PBS, fixed with 4% formaldehyde and viewed
under confocal laser scanning microscope at ex-
citation wavelengths of 488 and 514 nm.
Results
Cr(VI)-induced cytoskeletal damage
Staining of hepatocytes with phalloidin revealed a
highly integrated network of F-actin in control
Figure 1
Control hepatocytes in primary culture (24 h), stained
with phalloidin-FITC
Figure 2
Hepatocytes in primary culture exposed to 1 lM
Cr(VI) for 24 h and stained with phalloidin-FITC
cells (Figure 1). After 1 lM Cr(VI) treatment, a
number of cells had lost the entire F-actin net-
work, and the periphery of the cell membrane
appeared brighter and thicker than control cells
(Figure 2). In addition, some cells had also
developed small blebs on the cell membrane and
shrunk in size. After 5 lM Cr(VI) treatment these
effects became more pronounced.
Cr(VI)-induced mode of cell death
The mode of cell death was investigated using
annexin V-FITC. Annexin V is a binding protein
that has high affinity for phosphatidylserine,
which is present on the outer membrane surface
only of cells undergoing apoptosis [15]. In these
experiments the control cells showed somefluores-
cence, which was attributed to auto-fluorescence.
After exposure to 5 lM Cr(VI) cells were stained
bright green with annexin V around the cell
periphery, indicating that cells were undergoing
apoptosis. At 25 lM Cr(VI), the number of apop-
totic cells increased and there were cells which
were also stained red with propidium iodide.
Penetration of propidium iodide indicates damage
to the cell membrane, and is evidence for the
necrotic mode of cell death.
Discussion
This study has shown that Cr(VI) can induce
damage to the cell cytoskeleton at low concen-
trations (1 lM).Cr(VI) has previously been shown
to inhibit cytoskeletal protein synthesis in 3T3
cells [9], and to form complexes with -SH groups
of cellular proteins and reduced glutathione [10].
Cytoskeletal proteins contain numerous -SH
groups. Therefore, Cr(VI) may cause damage to
the cytoskeleton either by inhibiting the cyto-
skeletal protein synthesis and}or by forming com-
plexes with the -SH groups of the cytoskeletal
proteins. We have also shown that Cr(VI)-induced
cytoskeletal damage was accompanied by forma-
tion of blebs on the cell membrane and reduction
in the size of the cell. In some cells it was apparent
that these blebs were detaching from the mem-
brane. Formation of blebs (known as apoptotic
bodies) and shrinking of cells are indicators of the
mode of cell death known as apoptosis. Staining of
hepatocytes with annexin V has shown that low
concentrations (5 lM) of Cr(VI) caused apoptosis
in cultured hepatocytes. This induction of apop-
tosis was dose-dependent. Cr(VI) has been shown
to cause apoptosis in many studies [11–13]. We
have shown that Cr(VI) induces apoptosis at low
concentrations, and necrosis at higher concen-
trations.Themode of cell death plays an important
role in vivo since the process of apoptosis ter-
minates in the elimination of damaged cells
through phagocytosis without the induction of
a high inflammatory reaction, whereas necrosis
evokes an inflammatory reaction leading to severe
tissue destruction. High local concentrations of
Cr(VI) around the site of lose, unstable implants in
vivo may therefore contribute to osteolysis by
causing necrosis and tissue destruction, whereas
prolonged exposure to lower systemic Cr(VI)
concentrations through environmental contami-
nation may involve apoptosis rather than necrosis,
and tissue destruction may not be evident.
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